Recent Finacing
Recent Raise
CARsgen Therapeutics develops autologous and next-generation CAR‑T cell therapies for hematologic and solid tumors, with target screening, antibody optimization, CMC development, and multinational clinical programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at CARsgen Therapeutics.
